
Science Resources RSS Feeds
|
 |
 |
 |
Chronic infection persists by targeting stromal cell network in lymphoid organs
September 19, 2007
One of the biggest challenges to treating infectious diseases and developing preventive vaccines is the ability of many chronic infections to suppress the immune T-cell response over time. An Emory-led team of scientists has discovered one important way in which chronic viral infections are able to evade the immune response. The research is reported this week online in the Proceedings of the National Academy of Sciences. Using a mouse model, the scientists found that a chronic strain of lymphocytic choriomeningitis virus (LCMV) targeted a type of stromal cells in the lymphoid organs called fibroblastic reticular cells (FRC). In contrast, an acute strain of the virus had little effect on the FRC cells. FRC provide a three-dimensional framework used by immune cells to travel and interact with other immune cells within the lymphoid organs (spleen and lymph nodes). These FRC are important for the initiation of immune responses to infections. The researchers found that widespread infection of the FRC caused a disruption of the function of these important stromal cells.
Last year a group of Emory scientists led by Rafi Ahmed, PhD, and graduate student Daniel Barber and their colleagues discovered in mice another way in which the immune reaction to chronic infections is blocked -- a pathway called PD-1 that blocked the response to the chronic strain of LCMV.
The current research was conducted by Scott N. Mueller, PhD, a postdoctoral fellow in the laboratory of Dr. Ahmed, a Georgia Research Alliance Eminent Scholar and director of the Emory Vaccine Center. The team also included scientists from the Emory Transplant Center and Emory School of Medicine, the University of California, San Francisco (UCSF), the University of California, Los Angeles (UCLA), Harvard Medical School and the Dana-Farber Cancer Institute.
The research team discovered that infection of FRC may involve the previously discovered PD-1 pathway. The major ligand (binding molecule) for PD-1, PD-L1, is upregulated on FRC after infection. The PD-1 pathway may inhibit interactions between CD8+ T cells and FRC, preventing destruction of the FRC architecture in the spleen. This may help the virus to remain in infected FRC and contribute to long-term viral persistence.
"This research helps explain how the T-cell response can be suppressed in chronic viral infections," says Dr. Mueller. "As we learn more about the intricate mechanisms involved we will be able to develop better treatments, and potentially preventive vaccines, for chronic infections such as those caused by HIV and hepatitis C viruses."
Emory University
|
 |
Related Lymphoid Current Events and Lymphoid News Articles Lymphoid Current Events and Lymphoid News RSS Cell study explains why younger people more at risk of vCJD Specific cells within the immune system could help explain why younger people are more susceptible to variant CJD, scientists believe.
Is endotoxin receptor CD14 rs2569190/C-159T gene correlated with chronic hepatitis C? It is still unknown why the natural history of chronic disease caused by hepatitis C virus (HCV), which currently infects 3% of the world's population, varies from mild in some patients to rapidly progressing in others.
Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia Scientists at St. Jude Children's Research Hospital have identified inherited variations in two genes that account for 37 percent of childhood acute lymphoblastic leukemia (ALL), including a gene that may help predict drug response.
HIV uses autophagy for its own means Not satisfied with simply thwarting its host's defensive maneuvers, HIV actually twists one to its advantage, based on new findings from Kyei et al. in the July 27, 2009 issue of the Journal of Cell Biology (www.jcb.org). Vojo Deretic and colleagues suggest that autophagy-a stress response process-helps HIV to proliferate and that conversely, blocking autophagy lessens HIV production.
Research suggests new cellular targets for HIV drug development Focusing HIV drug development on immune cells called macrophages instead of traditionally targeted T cells could bring us closer to eradicating the disease, according to new research from University of Florida and five other institutions.
Process controlling T cell growth and production identified Identifying one of the processes that plays a role in naïve and memory T-cells' growth and production could one day lead to better vaccines and possibly more effective cancer immunotherapy.
NC State Researchers Find Soy May Aid in Treating Canine Cancers Researchers at North Carolina State University are looking to soy as a way to make traditional canine cancer therapy more effective, less stressful for the dog and less costly for the owners.
Helicobacter pylori can multiply in autophagic vesicles Helicobacter pylori, a Gram-negative, flagellated, microaerophilic bacterium, can selectively colonize in the human stomach. Its infection is widespread throughout the world, and is present in about 50% of the global human population with 80% in developing countries and 20-50% in industrialized countries.
New therapy prevents dangerous side effect for lymphoma patients Patients respond well to a new three-drug combination for indolent B cell lymphoma that also spares them prolonged, potentially lethal, suppression of blood production in the bone marrow, researchers at The University of Texas M. D. Anderson Cancer Center report today at the 50th annual meeting of the American Society of Hematology.
Potential breakthrough for T-Cell lymphoma patients with drug that mimics folic acid Preliminary results of a pivotal Phase 2 clinical trial of pralatrexate (PDX), a drug that partially works by mimicking folic acid, showed a complete or partial response in 27 percent of patients with recurrent or resistant peripheral T-cell lymphoma (PTCL). More Lymphoid Current Events and Lymphoid News Articles
|
 |

|
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue (IARC WHO Classification of Tumours)
by The International Agency for Research on Cancer (Author)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue is the third volume in the new WHO series on histological and genetic typing of human tumors. This authoritative, concise reference book covers the entire range of leukaemias and lymphomas. It provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies monitoring response to therapy and clinical outcome. Diagnostic criteria, pathological features, and associated genetic alterations are described in a strictly disease-oriented manner. Sections on all recognized neoplasms and their variants include new ICD-O codes, incidence, age and sex distribution, location, clinical signs and symptoms, pathology, genetics, and predictive factors.
|

|
The Cutaneous Lymphoid Proliferations: A Comprehensive Textbook of Lymphocytic Infiltrates of the Skin
by Cynthia M. Magro (Author), A. Neil Crowson (Author), Martin C. Mihm (Author)
A complete reference to the latest understanding of lymphocytic infiltrates The Cutaneous Lymphoid Proliferations provides a complete, authoritative treatment of the clinical features, phenotypes, pathogenesis, histopathology, diagnosis, and treatment of lymphocytic infiltrates of the skin. Incorporating the latest findings from the fields of light microscopy, immunohistochemistry, and flow cytometry, the book brings readers up to date on the most current thinking in the field. Those readers familiar with the authors' critically acclaimed The Melanocytic Proliferations will find a similar structure and the same attention to detail and quality in this latest reference. The book starts off with a clinical atlas and introduction to the ontogeny and biology of the...
|

|
Biopsy Interpretation Of The Skin Primary Non-lymphoid Neoplasms Of The Skin
by Lippincott Williams & Wilkins
Biopsy Interpretation of the Skin Primary Non-Lymphoid Neoplasms of the Skin : Biopsy Interpretation of the Skin Primary Non-Lymphoid Neoplasms of the Skin Pub Date: December 2009 Product Type: Print Author/s: A. Neil Crowson MD; Cynthia M Magro MD; Martin C Mihm Jr., MD This new volume of the Biopsy Interpretation Series is a practical, superbly illustrated reference on the primary non-lymphoid neoplasms of the skin. The book offers guidelines on how and when to biopsy the skin and then discusses benign melanocytic proliferations, precursor lesions to melanoma, and melanomas. Also included are discussions of basal cell carcinoma, squamous cell carcinoma and its precursors, benign and malignant adnexal neoplasms, and soft tissue neoplasms of the skin and superficial...
|

|
Gut-Associated Lymphoid Tissues (Current Topics in Microbiology and Immunology)
by T. Honjo (Editor), F. Melchers (Editor)
The intestine is colonized by an impressive community of commensals, that has profound effects on the immune funtions. The relationship between gut microbiota and the immune system is one of reciprocity: commensals have important contribution in nutrient processing and education of the immune system and conversely, the immune system, particularly gut-associated lymphoid tissues plays a key role in shaping the repertoire of gut microbiota.
|

|
Biopsy Interpretation of the Skin: Primary Non-Lymphoid Neoplasms of the Skin (Biopsy Interpretation Series)
by A. Neil Crowson (Author), Cynthia M Magro (Author), Martin C Mihm (Author)
This new volume of the Biopsy Interpretation Series is a practical, superbly illustrated reference on the primary non-lymphoid neoplasms of the skin. The book offers guidelines on how and when to biopsy the skin and then discusses benign melanocytic proliferations, precursor lesions to melanoma, and melanomas. Also included are discussions of basal cell carcinoma, squamous cell carcinoma and its precursors, benign and malignant adnexal neoplasms, and soft tissue neoplasms of the skin and superficial subcutis. A major highlight of the book is the extensive discussion of differential diagnostic considerations and their separation from the main diagnostic entities under consideration. The book features nearly 300 full-color images. A companion Website will provide 400 additional figures,...
|

|
Immunochemical Techniques, Part H: Effectors and Mediators of Lymphoid Cell Functions, Volume 116: Volume 116: Immunochemical Techniques Part H (Methods in Enzymology)
by Nathan P. Colowick (Editor), Nathan P. Kaplan (Editor), Giovanni Di Sabato (Editor), John J. Langone (Editor), Helen Van Vunakis (Editor)
The critically acclaimed laboratory standard, Methods in Enzymology, is one of the most highly respected publications in the field of biochemistry. Since 1955, each volume has been eagerly awaited, frequently consulted, and praised by researchers and reviewers alike. The series contains much material still relevant today - truly an essential publication for researchers in all fields of life sciences.
|
|
|
Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours)
by Elaine Sarkin Jaffe (Author)
"Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid System" is the third volume in the WHO series on histological and genetic typing of human tumours. This authoritative, concise reference book provides an international standard for pathologists and oncologists and will serve as an indispensable guide for use in the design of studies monitoring response to therapy and clinical outcome. The volume covers chronic myeloproliferative diseases, myeloplastic / myeloproliferative diseases, myelodisplastic syndromes, acute myeloid leukaemia, precursor B- and T-cell neoplasms, mature B-cell, T-cell and NK-cell neoplasms, Hodgkin lymphoma, immunodeficiency-associated lymphoproliferative disorders, histiocytic and dendritic cell neoplasms, and mastocytosis. Diagnostic...
|
|
|
Who Classification of Tumours of Haematopoietic and Lymphoid Tissue [WHO CLASS -OS DUE/019]
by Steven H.(Author) Who(Author) ; Swerdlow (Author)
|
|
|
The Lymphoid Neoplasms (Hodder Arnold Publication)
by Magrath (Author)
This comprehensive and authoritative reference covers all aspects of the group of disorders collectively known as the lymphoid neoplasms. The reader is taken through a description of its normal cellular origins and the molecular genetic abnormalities that can lead to this group of conditions, a section of the book that has been considerably strengthened for this third edition, to the environmental factors that may be relevant to disease development, and finally, to the pragmatic aspects of disease management. The authors synthesize for the reader aspects of current knowledge and likely future developments, and direct them to the appropriate resources should they wish to pursue particular avenues of scientific or literature research.
|
|
|
Dendritic Cells in Lymphoid Tissues: Proceedings of the First International Symposium of Dendritic Cells in Lymphoid Tissues, Held in Yamagata, Japa (International Congress Series)
by International Symposium on Dendritic Cells in Lymphoid Tissues 1990 y (Author), Yutaka Imai (Author), John G. Tew (Author), Elizabeth C. M. Hoefsmit (Author)
This book is based on the first symposium in the world to focus on dendritic cells. Prominent scholars from around the world focused their attention primarily on interdigitating cells (IDC) and follicular dendritic cells (FDC). With the recent developments of new methods of study, new problems have emerged. The volume reflects the newest research results on these problems and the discussions that took place, thereby elucidating the nature of dendritic cells and paving the way for further research in this field.
|
|